Skip to main content
. 2017 Nov 8;8:1519. doi: 10.3389/fimmu.2017.01519

Figure 7.

Figure 7

Depleting regulatory T cells (Tregs) largely reverses allograft survival extended by emodin. C57BL/6 mice received a skin graft from a BALB/c mouse and were treated with emodin or CsA. Tregs in recipient mice were depleted using anti-CD25 (PC61) and anti-CD122 (TMβ1). Skin allograft rejection was then observed (n = 6–7 grafts).